Morning Movers 3/11: SMTX, BPAX, ZANE, GYMB, CLNE, SMTC, DPS, LVLT, IMAX, MBLX, Higher; CSR, JTX, CLNE, MW, BUCY, AACC, BBBY Lower
SMTX Hot Sheet
EPS Growth %: +260.0%
SMTC Corp. (Nasdaq: SMTX) 55% HIGHER; reports Q4 EPS of $0.14, versus ($0.01) reported for the same period a year ago. Revenue for the quarter was $51.24 million, compared to $55.26 million in Q408.Z
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) 13% HIGHER; today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).
Zanett Inc. (NASDAQ: ZANE) 11% HIGHER;Possible short squeeze after rising from $0.31 on March 3 to over $3.00
China Security & Surveillance Technology, Inc. (NYSE: CSR) 11% LOWER; to offer up to 20M shares
Gymboree (NASDAQ: GYMB) 10% HIGHER; reports Q4 EPS of $1.11, 1 cent better than the analyst estimate of $1.10. Revenue for the quarter was $299.6 million, which compares to the estimate of $299.91 million. Gymboree sees Q1 EPS of $0.90-$0.94, versus the consensus of $0.90. Sees Q1 comps up mid-single digits.
Jackson Hewitt (NYSE: JTX) 6% LOWER; reports Q3 adjusted EPS of $0.46, versus the analyst estimate of $0.48. Revenue for the quarter was $79.1 million, which compares to the estimate of $83.41 million.
Clean Energy Fuels (NASDAQ: CLNE) 5.5% HIGHER; reports Q4 EPS of $0.02, 6 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $42.2 million, which compares to the estimate of $40.31 million.
Semtech Corp. (NASDAQ: SMTC) 5.2% HIGHER; reports Q4 non-GAAP EPS of $0.30, 8 cents better than the analyst estimate of $0.22. Revenue for the quarter was $85 million, which compares to the estimate of $76.93 million. Sees Q110 sales up 7 - 13% and a non-GAAP EPS of $0.27 - $0.30. Consensus sees revs of $79.56 and an EPS of $0.21.
Men's Wearhouse (NYSE: MW) 4% LOWER; reports Q4 loss of $0.11, 5 cents better than the analyst estimate of ($0.16). Revenue for the quarter was $457.22 million, which compares to the estimate of $465.94 million. Sees Q1 EPS of $0.12-$0.16, versus the consensus of $0.09. Sees comps flat to down low single-digits.
Dr Pepper Snapple Group, Inc. (NYSE: DPS) 4% HIGHER;Upgraded at UBS
Bucyrus International Inc. (NASDAQ: BUCY) 3% LOWER; Broadpoint.Amtech downgrades
Level 3 Communications Inc. (NASDAQ: LVLT) 3% HIGHER;Upgraded at JP Morgan to Neutral
IMAX (NASDAQ: IMAX) 3% HIGHER; reports Q4 adjusted EPS of $0.20, 13 cents better than the analyst estimate of $0.07. Revenue for the quarter was $54.24 million, which compares to the estimate of $45.28 million.
Asset Acceptance Capital Corp. (Nasdaq: AACC) 3% LOWER; reports Q4 loss of $0.66, which may not compare to the analyst estimate of ($0.01). Revenue for the quarter was $18.7 million.
Metabolix (NASDAQ: MBLX) 2.8% HIGHER; reports Q4 loss of $0.39, 5 cents better than the analyst estimate of ($0.44). Revenue for the quarter was $205,000, which compares to the estimate of $530,000.
Bed Bath & Beyond, Inc. (Nasdaq: BBBY) 2% LOWER; FBR downgrade
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) 13% HIGHER; today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).
Zanett Inc. (NASDAQ: ZANE) 11% HIGHER;Possible short squeeze after rising from $0.31 on March 3 to over $3.00
China Security & Surveillance Technology, Inc. (NYSE: CSR) 11% LOWER; to offer up to 20M shares
Gymboree (NASDAQ: GYMB) 10% HIGHER; reports Q4 EPS of $1.11, 1 cent better than the analyst estimate of $1.10. Revenue for the quarter was $299.6 million, which compares to the estimate of $299.91 million. Gymboree sees Q1 EPS of $0.90-$0.94, versus the consensus of $0.90. Sees Q1 comps up mid-single digits.
Jackson Hewitt (NYSE: JTX) 6% LOWER; reports Q3 adjusted EPS of $0.46, versus the analyst estimate of $0.48. Revenue for the quarter was $79.1 million, which compares to the estimate of $83.41 million.
Clean Energy Fuels (NASDAQ: CLNE) 5.5% HIGHER; reports Q4 EPS of $0.02, 6 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $42.2 million, which compares to the estimate of $40.31 million.
Semtech Corp. (NASDAQ: SMTC) 5.2% HIGHER; reports Q4 non-GAAP EPS of $0.30, 8 cents better than the analyst estimate of $0.22. Revenue for the quarter was $85 million, which compares to the estimate of $76.93 million. Sees Q110 sales up 7 - 13% and a non-GAAP EPS of $0.27 - $0.30. Consensus sees revs of $79.56 and an EPS of $0.21.
Men's Wearhouse (NYSE: MW) 4% LOWER; reports Q4 loss of $0.11, 5 cents better than the analyst estimate of ($0.16). Revenue for the quarter was $457.22 million, which compares to the estimate of $465.94 million. Sees Q1 EPS of $0.12-$0.16, versus the consensus of $0.09. Sees comps flat to down low single-digits.
Dr Pepper Snapple Group, Inc. (NYSE: DPS) 4% HIGHER;Upgraded at UBS
Bucyrus International Inc. (NASDAQ: BUCY) 3% LOWER; Broadpoint.Amtech downgrades
Level 3 Communications Inc. (NASDAQ: LVLT) 3% HIGHER;Upgraded at JP Morgan to Neutral
IMAX (NASDAQ: IMAX) 3% HIGHER; reports Q4 adjusted EPS of $0.20, 13 cents better than the analyst estimate of $0.07. Revenue for the quarter was $54.24 million, which compares to the estimate of $45.28 million.
Asset Acceptance Capital Corp. (Nasdaq: AACC) 3% LOWER; reports Q4 loss of $0.66, which may not compare to the analyst estimate of ($0.01). Revenue for the quarter was $18.7 million.
Metabolix (NASDAQ: MBLX) 2.8% HIGHER; reports Q4 loss of $0.39, 5 cents better than the analyst estimate of ($0.44). Revenue for the quarter was $205,000, which compares to the estimate of $530,000.
Bed Bath & Beyond, Inc. (Nasdaq: BBBY) 2% LOWER; FBR downgrade
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
UBS, JPMorgan, American Technology Research, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
